Markus Wild

Lacrimal Glands May Represent Organs at Risk for Radionuclide Therapy of Prostate Cancer with [177Lu]DKFZ-PSMA-617

Melanie Hohberg, W. Eschner, Matthias Schmidt et al. · Molecular Imaging and Biology · 2016 · 82 citations

Urology, Medicine, Radionuclide Therapy +6

Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?

Carsten Kobe, W. Eschner, Markus Wild et al. · Nuclear Medicine Communications · 2010 · 49 citations

Biodistribution and radiation dosimetry of [18F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer

Melanie Hohberg, Carsten Kobe, Philipp Krapf et al. · EJNMMI Research · 2019 · 29 citations · Full text

Combined Early and Late [68Ga]PSMA-HBED-CC PET Scans Improve Lesion Detectability in Biochemical Recurrence of Prostate Cancer with Low PSA Levels

Melanie Hohberg, Carsten Kobe, Philipp Täger et al. · Molecular Imaging and Biology · 2018 · 28 citations

Urology, Imaging Biomarkers, Oncology +12

Prediction of Response to¹⁷⁷Lu-PSMA Therapy Based on Tumor-to-Kidney Ratio on Pretherapeutic PSMA PET/CT and Posttherapeutic Tumor-Dose Evaluation in mCRPC

Melanie Hohberg, M. Reifegerst, Alexander Drzezga et al. · Journal of Nuclear Medicine · 2023 · 21 citations · Full text